iSpecimen Inc. Investment Income, Net
iSpecimen Inc. (ISPC) reported Investment Income, Net of $3.66 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2021-11-04
- iSpecimen Inc. investment income, net for the quarter ending 2021-09-30 was $3.66K, a 4105.75% increase year-over-year.
- iSpecimen Inc. investment income, net for the quarter ending 2021-06-30 was $172.00, a 100.00% increase year-over-year.
- iSpecimen Inc. investment income, net for the quarter ending 2020-09-30 was $87.00.
- iSpecimen Inc. investment income, net for the quarter ending 2020-06-30 was $86.00.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month |
|---|---|---|---|
| 2021-09-30 | $3.66K 10-Q · filed 2021-11-04 | $3.83K derived: sum of 2 quarters · filed 2021-11-04 | $3.88K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $172.00 10-Q · filed 2021-08-10 | ||
| 2020-09-30 | $87.00 10-Q · filed 2021-11-04 | $173.00 derived: sum of 2 quarters · filed 2021-11-04 | $396.00 10-Q · filed 2021-11-04 |
| 2020-06-30 | $86.00 10-Q · filed 2021-08-10 | $309.00 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |